17th Meet the Professor. Advanced International Breast Cancer Course

Mortality from breast cancer is declining in most countries thanks to effective screening programs, early diagnosis, molecular characterization of the different subtypes and biology-driven treatments. A multidisciplinary management of breast cancer patients is therefore the key to success and a breast multidisciplinary team should include - besides the “classic” clinical specialties - pathologists, molecular biologists and geneticists. Furthermore, the availability of multiple diagnostic and therapeutic choices, the increasing costs of new technologies and drugs and the issue of sustainability represent a new challenge for socially-responsible clinicians. With this goal in mind, the Programme includes lectures on molecular characterization, updated treatments of early and advanced disease, management of difficult cases and hereditary syndromes and issues of sustainability and drug access across countries.

Introduction - Pierfranco Conte, Gabriel N. Hortobagyi, Valentina Guarneri, Philip Poortmans

Obesity and Cancer - Roberto Vettor

Management of women BRCA 1/2 and other predisposition gene mutations - Shani Paluch-Shimon

Axillary dissection: still an option? - Elefterios Mamounas

Hot topics in breast cancer RT - Philip Poortmans

Clinical impact of genomics in BC - Aleix Prat

PIK3CA testing: from technical aspects to clinical application - Sybille Loibl

Prognostic signatures to guide treatment decision - Gabriel N. Hortobagyi

Adjuvant CDK4/6i for HR+ disease: reconciling data from randomized trials - Valentina Guarneri

Early BRCAm (BreastCancer mutation) tumors: PARPi are coming! - Pierfranco Conte

Neoadjuvant therapy for early breast cancer: beyond the pCR dogma - Pierfranco Conte

Immunotherapy for early TNBC: hopes and hypes - Hope Rugo

Antibody Drug Conjugates for BC - Frederik Marmè

Targeting unconventional pathways in Luminal BC - Maria Vittoria Dieci

Treatment algorithm for HR+/HER2- ABC - Stephen Johnston

Treatment algorithm for HER2+ ABC - Sandra Swain

Treatment algorithm and new options for TN ABC - Miguel Martin

Contenuti tecnico-professionali (conoscenze e competenze) specifici di ciascuna professione, di ciascuna specializzazione e di ciascuna attività ultraspecialistica, ivi incluse le malattie rare e la medicina di genere

Questionario a risposta multipla e a doppia randomizzazione. Si effettua online con l'obbligo di rispondere correttamente ad almeno il 75 percento delle domande per il suo superamento. È prevista la possibilità di ripetizione in caso di esito negativo